Inactive Instrument

Tabula Rasa HealthCare, Inc.

Equities

TRHC

US8733791011

Advanced Medical Equipment & Technology

Tabula Rasa HealthCare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 08, 2023 at 04:44 pm EDT

Tabula Rasa HealthCare, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 88.28 million compared to USD 67.11 million a year ago. Net loss was USD 15.9 million compared to USD 28.19 million a year ago.

Basic loss per share from continuing operations was USD 0.28 compared to USD 0.85 a year ago. Basic loss per share was USD 0.63 compared to USD 1.18 a year ago.

Latest news about Tabula Rasa HealthCare, Inc.

Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from S&P TMI Index	Nov. 07	CI
Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from S&P Global BMI Index	Nov. 07	CI
Tabula Rasa Healthcare, Inc. Announces Board Changes	Nov. 06	CI
Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from NASDAQ Composite Index	Nov. 03	CI
Exact Care Pharmacy, LLC completed the acquisition of Tabula Rasa HealthCare, Inc. from Indaba Capital Fund, L.P, managed by Indaba Capital Management, L.P. and others.	Nov. 02	CI
North American Morning Briefing : Sentiment Hit by -2-	23-08-08	DJ
Sector Update: Health Care Stocks Advancing in Late Afternoon Trading	23-08-07	MT
Sector Update: Health Care Stocks Rising in Afternoon Trading	23-08-07	MT
Top Midday Gainers	23-08-07	MT
Tabula Rasa HealthCare Enters With Plan of Merger With Nautic Partners Affiliate; Shares Rise Pre-Bell	23-08-07	MT
Tabula Rasa HealthCare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Earnings Flash (TRHC) TABULA RASA HEALTHCARE Reports Q2 Revenue $90M, vs. Street Est of $88.9M	23-08-07	MT
Exact Care Pharmacy, LLC entered into a definitive agreement to acquire Tabula Rasa HealthCare, Inc. from Indaba Capital Fund, L.P, managed by Indaba Capital Management, L.P. and others for approximately $320 million.	23-08-06	CI
Tabula Rasa Healthcare, Inc. Appoints Michael Bruno as Chief Accounting Officer	23-08-04	CI
SVB Securities Upgrades Tabula Rasa HealthCare to Outperform From Market Perform, Adjusts Price Target to $10 From $7	23-05-10	MT
Transcript : Tabula Rasa HealthCare, Inc., Q1 2023 Earnings Call, May 09, 2023	23-05-09
Tabula Rasa HealthCare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Earnings Flash (TRHC) TABULA RASA HEALTHCARE Posts Q1 Revenue $88.3M	23-05-08	MT
Tabula Rasa Healthcare, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023 and Full Year Ending December 31, 2023	23-05-08	CI
North American Morning Briefing : Caution Dominates Ahead of Bank Earnings	23-04-14	DJ
Tabula Rasa HealthCare Raises Q1 Revenue Guidance; Names Brian Adams as President, CEO	23-04-13	MT
Tabula Rasa Healthcare, Inc. Provides Revenue Guidance for the First Quarter of 2023	23-04-13	CI
Tabula Rasa Healthcare, Inc. Appoints Brian Adams as Chief Executive Officer	23-04-13	CI
Tabula Rasa Healthcare, Inc. Announces Executive Changes	23-04-13	CI
Transcript : Tabula Rasa HealthCare, Inc., Q4 2022 Earnings Call, Mar 07, 2023	23-03-07

Chart Tabula Rasa HealthCare, Inc.

Duration

Period

More charts

Company Profile

Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+4.36%	32.47B
PRO MEDICUS LIMITED	+14.14%	7.45B
SECTRA AB	+22.93%	3.89B
EVOLENT HEALTH, INC.	-16.29%	3.15B
OMNICELL, INC.	-25.96%	1.28B
LUNIT INC.	-36.14%	1.09B
B-SOFT CO.,LTD.	-35.42%	902M
SIMULATIONS PLUS, INC.	-0.13%	893M
VERADIGM INC.	-24.12%	857M

Medical Software & Technology Services